Targeting Calcitonin Gene-Related Peptide and its Receptor by Monoclonal Antibody, New Developments in the Prevention of Migraine
Journal Title: Neuro – Open Journal - Year 2015, Vol 2, Issue 3
Abstract
Migraine is a chronic headache disorder with an unknown pathophysiology. Research in the past decade has shown that to be a brain disorder, a dismodulation of sensory processing affecting vascular tone and pain1-3 but since the exact pathomechanism of migraine is not very well known, its treatment is also difficult. Current drugs recommended by the “European Federation of Neurological Societies (EFNS)” used in the treatment of migraine include the triptan family drugs that are serotonin (5-HT1B/D) receptor agonists, and the Non-Steroid Anti-Inflammatory Drugs (NSAIDs).4 Several other drugs such as anti-epileptic drugs, beta-blockers, and calcium channel blockers are also recommended in the treatment of migraine.4
Authors and Affiliations
Mohtashem Samsam
Keywords
Related Articles
- EP ID EP552601
- DOI 10.17140/NOJ-2-e004
- Views 152
- Downloads 0
Mobile Stroke Unit (MSU): The Future of Acute Stroke Treatment?
Time is the key factor in brain survivability in acute stroke treatment.1The therapeutic effects of intravenous recombinant tissue Plasminogen Activator (IV rtPA) are highly dependent on time.1-3 Stroke patients presenti...
Immunomodulatory Effects of Mesenchymal Stem Cells on T- and B-Cells in a Quiescent State in a Chronic Experimental Model of Autoimmune Encephalomyelitis
Introduction: Multiple sclerosis (MS) is an immune-mediated disease affecting the central nervous system (CNS). Many drugs have been tested in animal models of MS (e.g., Experimental Autoimmune Encephalomyelitis (EAE))....
Blue Cone Signals in the Extra Striate Cortex: Explanation for Blind Sight?
Our perception of vision is largely as a result of the signals conveyed from the eye to the brain via the retino-thalamo-cortical pathway. Visual signals within this pathway originate from three cone photoreceptors (resp...
New Criteria Reduce Inter-Observer Variability in Chronic Cerebrospinal Venous Insufficiency: A Case Control Study
Background: The pathophysiological mechanism defined “chronic cerebrospinal venous insufficiency” (CCSVI) diagnosed using Zamboni criteria has raised a heated debate about possible correlations with several neurological...
Current Utilization of Mast Cell Stabilizers for Preemptive Treatment of NF1 Neurofibromas
The morbidity and mortality of Neurofibromatosis type I (NF1) are both largely related to the person’s neurofibroma burden. That burden can presently be minimized by mast cell stabilizers, with ketotifen as the one most...